在刑事司法环境中使用数字健康和数字疗法治疗物质使用障碍：一项综述。
Use of Digital Health and Digital Therapeutics to Treat SUD in Criminal Justice Settings: a Review.
作者信息
Sawyer-Morris Ginnie, Wilde Judith A, Molfenter Todd, Taxman Faye
机构信息
Addiction Policy Forum, 4701 Sangamore Rd, Ste 100N-1173, Bethesda, MD 20816, USA.
Schar School of Policy and Government, George Mason University, 3351 Fairfax Drive, Arlington, VA 22201, USA.
出版信息
Curr Addict Rep. 2024 Feb;11(1):149-162. doi: 10.1007/s40429-023-00523-1. Epub 2023 Dec 27.
PURPOSE OF REVIEW
The purpose of this review is to investigate the use of digital health technologies and/or digital therapeutics (DTx) products in the treatment of substance use disorders (SUDs) in the general population and among criminal justice-involved individuals.
RECENT FINDINGS
Despite an expanding evidence base, only three SUD DTxs have received federal regulatory approval. Across studies, DTx products have proven successful in engaging patients in SUD treatment and reducing healthcare costs and resource utilizations. Findings for emerging SUD DTx products show similar results. Still, there is a paucity of evidence regarding the use of digital health technologies and/or DTx among criminal justice populations.
SUMMARY
DTxs have proven effective for treating multiple SUD types (e.g., nicotine and opioids) among the general population. DTx shows similar promise among justice-involved populations, but additional efficacy and implementation research is needed to address barriers such as cost, cultural resistance, and infrastructure.
综述目的
本综述旨在研究数字健康技术和/或数字疗法（DTx）产品在普通人群以及涉及刑事司法的个体中治疗物质使用障碍（SUDs）的应用情况。
最新发现
尽管证据基础不断扩大，但仅有三种SUD DTx产品获得了联邦监管批准。在各项研究中，DTx产品已证明在促使患者参与SUD治疗以及降低医疗成本和资源利用方面取得了成功。新兴SUD DTx产品的研究结果显示出类似的效果。然而，关于数字健康技术和/或DTx在刑事司法人群中的使用，证据仍然匮乏。
总结
DTx已被证明对普通人群中的多种SUD类型（如尼古丁和阿片类药物）有效。DTx在涉及司法的人群中也显示出类似的前景，但需要更多的疗效和实施研究来解决成本、文化阻力和基础设施等障碍。
Zotero 插件